Literature DB >> 3947294

Rebleeding after traumatic hyphema.

M A Thomas, R K Parrish, W J Feuer.   

Abstract

We reviewed the medical records of 175 patients who were admitted between 1977 and 1984 with a diagnosis of traumatic hyphema to define the incidence of operative intervention for the treatment of complications related to rebleeding. Of the 156 patients admitted with primary hyphemas, 25 (16%) rebled during hospitalization. Seven of these 25 in-hospital rebleeds required surgical intervention. Nineteen other patients were admitted with ocular histories and examinations strongly suggestive of rebleeding prior to admission (secondary hyphema--presumed preadmission rebleed). Seven of these 19 eyes underwent surgery. Of the 175 eyes studied, only one eye that did not rebleed underwent surgery during the initial hospitalization. Fourteen (32%) of 44 eyes that rebled underwent operative intervention. Nine of these 14 patients were operated on under general anesthesia. Potential benefits of newer hyphema treatments, such as epsilon-aminocaproic acid, designed to prevent rebleeding should be weighed against not only the ocular risks of rebleeding but also the risks of general anesthesia.

Entities:  

Mesh:

Year:  1986        PMID: 3947294     DOI: 10.1001/archopht.1986.01050140060020

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Traumatic hyphaema: a retrospective study of 314 cases.

Authors:  P Kearns
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

2.  Contemporary aspects in the prognosis of traumatic hyphemas.

Authors:  Dimitris Papaconstantinou; Ilias Georgalas; Nikos Kourtis; Eftimios Karmiris; Chrysanthi Koutsandrea; Ioannis Ladas; Gerasimos Georgopoulos
Journal:  Clin Ophthalmol       Date:  2009-06-02

3.  Global Current Practice Patterns for the Management of Hyphema.

Authors:  Sarah C Miller; Prajna Meeralakshmi; Michael J Fliotsos; Grant A Justin; Yoshihiro Yonekawa; Ariel Chen; Annette K Hoskin; Richard J Blanch; Kara M Cavuoto; Rebecca Low; Ximin Li; Matthew Gardiner; T Y Alvin Liu; Ankoor S Shah; James D Auran; Rupesh Agrawal; Fasika A Woreta
Journal:  Clin Ophthalmol       Date:  2022-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.